CTOs on the Move

New York Blood Center

www.ccmail.org

 
New York Blood Center is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 100-250
  • Annual Revenue: $250-500 Million
  • www.ccmail.org
  • 150 Amsterdam Ave
    New York, NY USA 10023
  • Phone: 212.468.2150

Executives

Name Title Contact Details

Similar Companies

Podimetrics

Podimetrics is a virtual care management company dedicated to preventing costly and deadly diabetic amputations. We provide high-risk patients our FDA-cleared SmartMatâ„¢ through partnerships with payers and at-risk providers, including the Veterans Health Administration. After placing their feet on the mat for just 20 seconds a day, patients` data are automatically sent to our care management team, which helps address any concerning findings. By combining cutting-edge technology with best-in-class care management, Podimetrics earns high engagement rates from patients, and allows clinicians to achieve unparalleled outcomes - keeping vulnerable patients healthy at home and saving limbs, lives, and money. Founded in 2011 by a physician and engineers from MIT and Harvard, Podimetrics is headquartered in Somerville, MA and backed by Norwich Ventures, Scientific Health Development, Polaris Partners, and Rock Health.

Vitale Group

Vitale Group is a Lutherville Timonium, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Calibrate

Calibrate is a Carrboro, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

GI Dynamics Inc

GI Dynamics Inc is a Lexington, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cordis

With more than a 60-year history of pioneering products to treat millions of patients, Cordis is a worldwide leader in the development and manufacturing of interventional cardiovascular technology. Cordis established a legacy of high-quality and minimally-invasive cardiovascular products; and has built a robust global footprint with operations in more than 60 countries around the world. As from August 2, 2021, Cordis is a standalone company, and is committed to investing $300 million to accelerate innovation in its broad product portfolio. Building on our storied brand, we are unleashing our potential to be a $10 billion leader bringing new technology to the market through bold action at speed.